Inflammation and lipid-lowering treatment

Current Cardiology Reports

Volumn 1, Issue 3, 1999, Pages 251-255

  Ballantyne, Christie M ^a   Abe, Yasunori ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INFLAMMATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR;

ANTILIPEMIC AGENTS; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; HUMANS; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033187272     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-999-0031-y     Document Type: Article

References (39)

1. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Cybulsky MI, Gimbrone MA Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251:788-791.
3. Poston RN, Haskard DO, Coucher JR, et al.: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992, 140:665-673.
4. Van Der Wal AC, Das PK, Tigges AJ, Becker AE: Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 1992, 141:1427-1433.
5. Davies MJ, Gordon JL, Gearing AJH, et al.: The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993, 171:223-229.
6. O'Brien KD, Allen MD, McDonald TO, et al.: Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. J Clin Invest 1993, 92:945-951.
7. Wood KM, Cadogan MD, Ramshaw AL, Parums DV: The distribution of adhesion molecules in human atherosclerosis. Histopathology 1993, 22:437-444.
8. Nakai K, Itoh C, Kawazoe K, et al.: Concentration of soluble vascular cell adhesion molecule-1 (VCAM-1) correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta. Coron Artery Dis 1995, 6:497-502.
9. O'Brien KD, McDonald TO, Chait A, et al.: Neovascular expression of E-selectin, intercellular adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996, 93:672-682.
10. Poston RN, Johnson-Tidey RR: Localized adhesion of monocytes to human atherosclerotic plaques demonstrated in vitro: implications for atherogenesis. Am J Pathol 1996, 149:73-80.
11. Springer TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995, 57:827-872.
12. Cybulsky MI, Gimbrone MA Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251:788-791.
13. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P: An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993, 13:197-204.
14. Richardson M, Hadcock SJ, DeReske M, Cybulsky MI: Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb 1994, 14:760-769.
15. Sakai A, Kume N, Nishi E, Tanoue K, Miyasaka M, Kita T: P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes. Arterioscler Thromb Vasc Biol 1997, 17:310-316.
16. Nakashima Y, Raines EW, Plump AS, et al.: Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998, 18:842-851.
17. Kume N, Cybulsky MI, Gimbrone MA Jr: Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992, 90:1138-1144.
18. Khan BV, Parthasarathy SS, Alexander RW, Medford RM: Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995, 95:1262-1270.
19. Vora DK, Fang ZT, Liva SM, et al.: Induction of P-selectin by oxidized lipoproteins: separate effects on synthesis and surface expression. Circ Res 1997, 80:810-818.
20. Allen S, Khan S, Al-Mohanna F, et al.: Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J Clin Invest 1998, 101: 1064-1075.
21. Cockerill GW, Rye K-A, Gamble JR, et al.: High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995, 15:1987-1994.
22. Cockerill GW, Saklatvala J, Ridley SH, et al. High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2. Arterioscler Thromb Vasc Biol 1999, 19: 910-917.
23. De Caterina R, Cybulsky MI, Clinton SK, et al.: The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994, 14:1829-1836.
24. Gearing AJH, Newman W: Circulating adhesion molecules in disease. Immunol Today 1993, 14:506-512.
25. Adams DH, Mainolfi E, Elias E, et al.: Detection of circulating intercellular adhesion molecule-1 after liver transplantation: evidence of local release within the liver during graft rejection. Transplantation 1993, 55:83-87.
26. Ballantyne CM, Mainolfi EA, Young JB, et al.: Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survival. J Heart Lung Transplant 1994, 13:597-603.
27. Hackman A, Abe Y, Insull W Jr, et al.: Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996, 93:1334-1338.
28. Abe Y, El-Masri B, Kimball KT, et al.: Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol 1998, 18:723-731.
29. Sampietro T, Palombo C, Iazzolino E, et al.: Improvement of endothelial adhesiveness and carotid artery geometry by short term atorvastatin therapy [abstract]. Circulation 1998, 98:I-240.
30. Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature 1990, 343:425-430.
31. Collins T, Read MA, Neish AS, et al.: Transcriptional regulation of endothelial cell adhesion molecules: NF-kB and cytokineinducible enhancers. FASEB J 1995, 9:899-909.
32. Hsueh YP, Lai MZ: c-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes. J Biol Chem 1995, 270:18094-18098.
33. Weber C, Erl W, Weber KS, Weber PC: HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J Am Coll Cardiol 1997, 30:1212-1217.
34. Kimura M, Kurose I, Russell J, Granger DN: Effects of fluva-statin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats. Arterioscler Thromb Vasc Biol 1997, 17:1521-1526.
35. Hwang S-J, Ballantyne CM, Sharrett AR, et al.: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997, 96:4219-4225.
36. Ridker PM, Hennekens CH, Roitman-Johnson B, et al.: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998, 351:88-92.
37. Ridker PM: Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Intern Med 1999; 130:933-937.
38. Ridker PM, Cushman M, Stampfer MJ, et al.: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979.
39. Ridker PM, Rifai N, Pfeffer MA, et al., for the Cholesterol and Recurrent Events (CARE) Investigators: Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998, 98: 839-844.